Adrenal Metastases
Showing 1 - 25 of 3,516
Adrenal Gland Metastases Trial in Rozzano (Stereotactic Body Radiation Therapy)
Active, not recruiting
- Adrenal Gland Metastases
- Stereotactic Body Radiation Therapy
-
Rozzano, Milan, ItalyHumanitas Research Hospital
May 3, 2022
Pancreas Cancer, Lung Cancer, Renal Cancer Trial in Boston (MR-guided Linac)
Recruiting
- Pancreas Cancer
- +12 more
- MR-guided Linac
-
Boston, Massachusetts
- +1 more
Sep 21, 2021
Conversion in Posterior Retroperitoneal Adrenalectomy by
Completed
- Adrenal Tumor
- +5 more
- Posterior retroperitoneal adrenalectomy (PRA)
- Lateral transperitoneal adrenalectomy (LTA)
-
Basel, SwitzerlandSimone Eichelberger
Aug 27, 2019
Colorectal Cancer Metastatic, Liver Metastasis Colon Cancer Trial (Stereotactic Body Radiotherapy, Microwave Ablation)
Recruiting
- Colorectal Cancer Metastatic
- Liver Metastasis Colon Cancer
- Stereotactic Body Radiotherapy
- Microwave Ablation
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC
Dec 18, 2022
NSCLC, Stage IV, Oligometastasis Trial in Netherlands, Spain, Switzerland (drug, radiation, procedure)
Active, not recruiting
- Non-small Cell Lung Cancer
- +2 more
- Durvalumab
- +6 more
-
Milano, Italy
- +12 more
Dec 14, 2022
Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))
Recruiting
- Oligoprogressive
- Castration-Resistant Prostate Cancer
- Stereotactic Body Radiation Therapy (SABR)
-
Toronto, Ontario, CanadaOdette Cancer Centre
Apr 9, 2021
Metastatic Tumors Trial in Worldwide (Stereotactic ablative radiotherapy, palliative radiotherapy)
Active, not recruiting
- Metastatic Tumors
- Stereotactic ablative radiotherapy
- palliative radiotherapy
-
Melbourne, Victoria, Australia
- +9 more
Apr 5, 2022
Metastatic Tumors Trial in Prince George (Stereotactic Ablative Body Radiotherapy)
Active, not recruiting
- Metastatic Tumors
- Stereotactic Ablative Body Radiotherapy
-
Prince George, British Columbia, CanadaBC Cancer
Apr 6, 2022
Prostatic Tumors Trial in Toronto (stereotactic radiotherapy)
Active, not recruiting
- Prostatic Neoplasms
- stereotactic radiotherapy
-
Toronto, Ontario, CanadaSunnybrook Odette Cancer Centre
Mar 6, 2022
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Polycystic Ovary Syndrome Trial in Odense (Escitalopram 20 mg, Placebo)
Completed
- Polycystic Ovary Syndrome
- Escitalopram 20 mg
- Placebo
-
Odense, DenmarkOdense Universitetshospital
Apr 24, 2023
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore
Recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +2 more
- 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
-
Singapore, Singapore
- +6 more
Oct 26, 2023
Pemphigoid, Bullous, Adrenal Insufficiency Trial in Bordeaux (clobetasol decreasing measurement)
Not yet recruiting
- Pemphigoid, Bullous
- Adrenal Insufficiency
- clobetasol decreasing measurement
-
Bordeaux, FranceUniversity Hospital of Bordeaux - Hospital Saint André
Nov 17, 2023
Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy Trial in Canada (Single fraction SABR, Multiple fraction
Not yet recruiting
- Oligometastatic Disease
- +3 more
- Single fraction SABR
- +3 more
-
Kelowna, British Columbia, Canada
- +4 more
Mar 23, 2023
Primary Adrenal Insufficiency Trial in Berlin, Bergen, Stockholm (diagnostic test, device, other)
Active, not recruiting
- Primary Adrenal Insufficiency
- Cosyntropin stimulation test
- +3 more
-
Berlin, Germany
- +2 more
Nov 3, 2022
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
Risk of Metastatic Disease in PPGLs,Retrospective Cohort Study
Not yet recruiting
- Paraganglioma
- +6 more
-
Copenhagen, Denmark
- +1 more
Mar 9, 2021
Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)
Not yet recruiting
- Triple Negative Breast Cancer
- Proleukin 1.3 MG Injection
- (no location specified)
Apr 6, 2023
Brain Metastases, Generalized Malignancy, Primary, Brain Lesions Trial in Tampa (TPI 287, Fractionated Stereotactic Radiotherapy
Terminated
- Brain Metastases
- +2 more
- TPI 287
- Fractionated Stereotactic Radiotherapy (FSRT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Feb 3, 2021
Adrenal Vein Sampling asTool to Identify Biomarkers That Aid
Recruiting
- Adrenocortical Carcinoma
- Blood sampling.
-
Rotterdam, NetherlandsErasmus MC
Dec 14, 2022
Aldosterone-producing Adenoma and Unilateral Hyperplasia
Not yet recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
- histopathology
-
Chongqing, ChinaThe Third Affiliated Hospital of the Third Military Medical Univ
Jun 28, 2023
Radiotracer, Hypertension, Cholesterol Trial in Ann Arbor (Dexamethasone (Group 2), Cosyntropin (Group 3), PET/CT Scan with
Recruiting
- Radiotracer
- +2 more
- Dexamethasone (Group 2)
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Dec 9, 2022
Melanoma, NSCLC, Brain Metastases Trial in New Haven (MK-3475)
Completed
- Melanoma
- +2 more
-
New Haven, ConnecticutSmilow Cancer Center at Yale New Haven Hospital
Mar 22, 2021
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Aldosterone-Producing Adenoma Trial (CXCR4)
Not yet recruiting
- Aldosterone-Producing Adenoma
- CXCR4
- (no location specified)
Apr 20, 2023